Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-F Emile

Showing results (21-30 of 114) with videos related to

Pageof 12
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1995
In situ expression of activation markers by Langerhans' cells containing GM-CSFJ F Emile, S Fraitag, M Leborgne, et al.
European Journal of Immunology|February 1, 1997
Sensitivity of Epstein-Barr virus-induced B cell tumor to apoptosis mediated by anti-CD95/Apo-1/fas antibodyA Durandy, F Le Deist, J F Emile, et al.
The Journal of Pathology|October 1, 1994
Langerhans' cell histiocytosis cells are activated Langerhans' cellsJ F Emile, S Fraitag, M Leborgne, et al.
Neuro-Chirurgie|October 3, 2018
A case of Erdheim-Chester disease with spinal cord compression and sphenoid sinus involvementK Bunaux, H Sevestre, J-F Emile, et al.
Annales De Pathologie|March 1, 1997
[Congenital asplenia. A childhood immune deficit often detected too late]S Ferlicot, J F Emile, J L Le Bris, et al.
Archives Francaises De Pediatrie|April 1, 1993
[Myxoma of the pulmonary infundibulum as the cause of sudden death in an 18-month-old infant]J F Emile, C Rambaud, D Canioni, et al.
American Journal of Hematology|July 1, 1994
Epstein-Barr virus-associated Hodgkin's disease following renal transplantationA Jaccard, J F Emile, F Metivier, et al.
Histopathology|March 22, 2001
Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinomaJ F Emile, A Lemoine, D Azoulay, et al.
Histopathology|February 24, 2001
Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteriaD Canioni, N Jabado, E MacIntyre, et al.
British Journal of Haematology|August 1, 1997
Detection of donor-derived Langerhans cells in MHC class II immunodeficient patients after allogeneic bone marrow transplantationJ F Emile, E Haddad, S Fraitag, et al.
Pageof 12

Showing results (21-30 of 114) with videos related to

Sort By:
Pageof 12
Advances in Experimental Medicine and Biology|January 1, 1995
In situ expression of activation markers by Langerhans' cells containing GM-CSFJ F Emile, S Fraitag, M Leborgne, et al.
European Journal of Immunology|February 1, 1997
Sensitivity of Epstein-Barr virus-induced B cell tumor to apoptosis mediated by anti-CD95/Apo-1/fas antibodyA Durandy, F Le Deist, J F Emile, et al.
The Journal of Pathology|October 1, 1994
Langerhans' cell histiocytosis cells are activated Langerhans' cellsJ F Emile, S Fraitag, M Leborgne, et al.
Neuro-Chirurgie|October 3, 2018
A case of Erdheim-Chester disease with spinal cord compression and sphenoid sinus involvementK Bunaux, H Sevestre, J-F Emile, et al.
Annales De Pathologie|March 1, 1997
[Congenital asplenia. A childhood immune deficit often detected too late]S Ferlicot, J F Emile, J L Le Bris, et al.
Archives Francaises De Pediatrie|April 1, 1993
[Myxoma of the pulmonary infundibulum as the cause of sudden death in an 18-month-old infant]J F Emile, C Rambaud, D Canioni, et al.
American Journal of Hematology|July 1, 1994
Epstein-Barr virus-associated Hodgkin's disease following renal transplantationA Jaccard, J F Emile, F Metivier, et al.
Histopathology|March 22, 2001
Histological, genomic and clinical heterogeneity of clear cell hepatocellular carcinomaJ F Emile, A Lemoine, D Azoulay, et al.
Histopathology|February 24, 2001
Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteriaD Canioni, N Jabado, E MacIntyre, et al.
British Journal of Haematology|August 1, 1997
Detection of donor-derived Langerhans cells in MHC class II immunodeficient patients after allogeneic bone marrow transplantationJ F Emile, E Haddad, S Fraitag, et al.
Pageof 12